On June 18, 2025, the U.S. Food and Drug Administration (“FDA”) announced an immediate review of new clinical trials that ...

The agency said it issued the import alerts because it “continues to have concerns related to outstanding Quality System ...

PYC Therapeutics advances VP-001 for retinitis pigmentosa, gaining FDA insights for its upcoming registrational trial.

Bristol Myers (BMY) receives FDA approval for label updates for Breyanzi and Abecma, that can ease access to the cancer cell ...

In November, a Ninth Circuit panel reversed a preliminary injunction, finding that the plaintiffs have no standing to ...

Oral DehydraTECH-liraglutide showed a pronounced reduction in adverse events (“AEs”) as compared to injected liraglutide (Saxenda(R)) Lexaria has now demonstrated, in distinct ...

During the forum, we not only introduced the company, but also held talks with a number of potential partners, distributors and manufacturers from Indonesia, the Philippines and other countries in the ...

FDA Establishment Identifier (FEI): Confirms Optimi's status as an FDA-registered pharmaceutical manufacturer—required for listing drug products, filing applications, and supplying U.S ...

Mr Demiah advised consumers to examine product labels thoroughly, ensuring they bear a valid FDA registration number, clearly marked expiry dates, information on the source and producer, and that ...

FDA Establishment Identifier (FEI): Confirms Optimi's status as an FDA-registered pharmaceutical manufacturer-required for listing drug products, filing applications, and supplying U.S ...

Number of new drugs approved. Between 2016 and 2024, the NMPA approved a total of 1,100 new drug applications, including 692 (63%) chemical drugs, 368 (33%) biological products, and 40 (4% ...